Skip to main content
logo
First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
41.73
+1.27 (3.14%)
At close: Sep 8, 2026, 4:00 PM EDT
41.80
+0.07 (0.17%)
After-hours: Sep 8, 2026, 7:39 PM EDT

TRAX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-160.3-166.09-163.71-106.15
Depreciation & Amortization
1.552.422.42.38
Loss (Gain) From Sale of Investments
-1.33-4.73-10.31-10.52
Stock-Based Compensation
36.7232.326.8318.39
Change in Accounts Payable
11.12-5.3117.818.39
Change in Other Net Operating Assets
-11.51-1.521.18-5.49
Operating Cash Flow
-123.76-142.93-125.81-93
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.06-0.09-0.36-0.81
Investment in Securities
211.8228.1295.76145.56
Investing Cash Flow
211.74228.0395.4144.75

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
316.5830.01117.52-
Other Financing Activities
-280.83---87.09
Financing Cash Flow
35.7430.01117.52-87.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
123.72115.1287.12-35.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-123.82-143.01-126.16-93.81
Free Cash Flow Growth
----
Levered Free Cash Flow
--82.76-63.42-
Unlevered Free Cash Flow
--82.76-63.42-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
-0.39-6.8318.992.9